Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response — which in severe cases can be life-threatening. A team of researchers has now identified a promising bioactive compound that could effectively reduce symptoms and slash fatality risk. The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- This common vaccine cuts heart risk nearly in half in new study
- The surprising cancer link between cats and humans
- He survived 48 hours without lungs and lived
- DNA origami vaccines could be the next leap beyond mRNA
- Scientists inject one tumor and watch cancer vanish across the body
- A lab mistake at Cambridge reveals a powerful new way to modify drug molecules
- Severe COVID or flu may raise lung cancer risk years later
- Parents’ stress may be quietly driving childhood obesity, Yale study finds
- Golden Retriever genes linked to anxiety, aggression, and intelligence in humans
- A bold new plan could finally cure type 1 diabetes
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
